Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and effects of calcifediol 0.266 milligrams soft capsules monthly and cholecalciferol 25000 international units monthly in osteoporotic women undergoing therapy with alendronate: a cross-sectional study.
Giampà E, Celletti E, DI Bonito M, Ferretti V, Gigliotti P, Nuvoli G, Paoletti F, Piazzini M, Ranieri M, Vinicola V. Giampà E, et al. Among authors: piazzini m. Minerva Endocrinol (Torino). 2024 Apr 4. doi: 10.23736/S2724-6507.24.03920-4. Online ahead of print. Minerva Endocrinol (Torino). 2024. PMID: 38576377
Improving Walking Energy Efficiency in Transtibial Amputees Through the Integration of a Low-Power Actuator in an ESAR Foot.
Mazzarini A, Fagioli I, Eken H, Livolsi C, Ciapetti T, Maselli A, Piazzini M, Macchi C, Davalli A, Gruppioni E, Trigili E, Crea S, Vitiello N. Mazzarini A, et al. Among authors: piazzini m. IEEE Trans Neural Syst Rehabil Eng. 2024;32:1397-1406. doi: 10.1109/TNSRE.2024.3379904. Epub 2024 Mar 28. IEEE Trans Neural Syst Rehabil Eng. 2024. PMID: 38507380
Comparing the effects of augmented virtual reality treadmill training versus conventional treadmill training in patients with stage II-III Parkinson's disease: the VIRTREAD-PD randomized controlled trial protocol.
Lombardi G, Baccini M, Gualerzi A, Pancani S, Campagnini S, Doronzio S, Longo D, Maselli A, Cherubini G, Piazzini M, Ciapetti T, Polito C, Pinna S, De Santis C, Bedoni M, Macchi C, Ramat S, Cecchi F. Lombardi G, et al. Among authors: piazzini m. Front Neurol. 2024 Jan 24;15:1338609. doi: 10.3389/fneur.2024.1338609. eCollection 2024. Front Neurol. 2024. PMID: 38327625 Free PMC article.
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations.
Vignoli M, Scaini MC, Ghiorzo P, Sestini R, Bruno W, Menin C, Gensini F, Piazzini M, Testori A, Manoukian S, Orlando C, D'Andrea E, Bianchi-Scarrà G, Genuardi M. Vignoli M, et al. Among authors: piazzini m. Melanoma Res. 2008 Dec;18(6):431-7. doi: 10.1097/CMR.0b013e328319412f. Melanoma Res. 2008. PMID: 19011513
The p.G23S CDKN2A founder mutation in high-risk melanoma families from Central Italy.
Gensini F, Sestini R, Piazzini M, Vignoli M, Chiarugi A, Brandani P, Ghiorzo P, Salvini C, Borgognoni L, Palli D, Bianchi-Scarrà G, Carli P, Genuardi M. Gensini F, et al. Among authors: piazzini m. Melanoma Res. 2007 Dec;17(6):387-92. doi: 10.1097/CMR.0b013e3282f1d328. Melanoma Res. 2007. PMID: 17992122
29 results